Meet Our Featured Speakers

benefits

Viral Vectors Summit 2026 delivers valuable market intelligence and expert insights on the latest advancements in viral vector technologies, precision gene therapies, and biomanufacturing processes.

Benefits of attending include:

Two days of focused presentations sharing the latest market insights in viral vector therapeutics, with an emphasis on research findings and industry experiences.
An exclusive networking opportunity to connect with professionals addressing challenges in viral vector design and gene therapy delivery, while exchanging insights from past and ongoing development projects.
Updates on regional projects and research from leading biotechnology and pharmaceutical manufacturing experts, sharing their experiences, findings, and recommendations.
Technical presentations from CGT professionals showcasing results from recent studies and trials, technological advancements, and emerging technical expertise.
Case studies from leading industry experts on de-risking viral vector programs through dose adjustment, patient stratification, and immune risk mitigation.
A unique opportunity to connect with industry stakeholders and explore innovations that address key challenges in the cell and gene therapy sector.

key takeaways

Understand the current market dynamics of the viral vector and gene therapy industry, and how they influence biotherapeutic development and commercialization strategies
Learn strategies for successful viral vector design, optimization, and GMP-compliant production within the gene therapy sector
Hear the latest trends in viral vector technologies, including advancements in vector engineering, innovative delivery systems, and future market outlooks
Discuss new manufacturing innovations and technological advancements in viral bioprocessing, with a focus on process optimization, automation, and scalability across both upstream and downstream operations
Access diverse insights and perspectives from experts across global markets and allied industries, combining regional experiences in viral vector development, regulatory compliance, and clinical implementation

who should attend?

This event brings together leading pharmaceutical companies, biotechnology organizations, and healthcare stakeholders interested in exploring viral vector systems and their future applications.

Core attendees include CEOs, COOs, CFOs, Presidents, Vice Presidents, Directors, Heads of, Superintendents, and Managers involved in:

Viral Vector Development Viral Vector Manufacturing Business Development Viral Vector Delivery Drug Formulation Clinical Trials and Approvals Viral Vector Discovery Laboratory Equipment Manufacturing R&D Biotherapeutics and Biologics Clinical Diagnostics Research and Development Biotechnology Research Companion Diagnostics Strategies and Public Health Nanotechnologies Theragnostic Legal and Regulatory Molecular Medicine System Biology and Research Equipment Certification Services Modalities Research Precision Medicine News Reporting and Journalism

they've attended our events

Brett Hill

Arcturus Therapeutics

"The event provides great exposure to industry leaders."

Xu Han

Orna Therapeutics

"Inspiring conference offering a broad range of insightful, relevant topics."

Alice Spenlehauer

DNA Script

"The forum was of high-quality."

Daniel Dixon

TriLink BioTechnologies

"Outstanding session with excellent content."

Ramesh Dasari

Sanofi

"Amazing programme covering novel ionizable lipids, LNP barcoding, and bioanalytical methods."

Muriel Lemaitre

Hongene Biotech Corporation

"Insightful talks paired with valuable industry networking opportunities."

SUBSCRIBE FOR UPDATES

By submitting, you agree to receive email communications from the event organizers, including upcoming promotions and discounted tickets, news, and access to related events.